Sildenafil (Generic): Month-by-Month Results for the First 3 Months

At a glance
- Starting dose / 50 mg in most adults; 25 mg in men over 65 or on certain medications
- Onset of action / 30 to 60 minutes; peak plasma concentration at ~60 minutes
- Duration / effective window is 4 to 6 hours for most men
- Response rate / ~70 to 80% of men with ED in randomized controlled trials
- Typical dose adjustment window / weeks 2 to 4, based on tolerability and response
- Common early side effects / facial flushing, headache, nasal congestion (each in 10 to 15% of users)
- Time to stable results / most men reach optimal response by weeks 8 to 12
- Contraindication / any nitrate medication (absolute); caution with alpha-blockers
How Sildenafil Works: The Pharmacology Behind the First Dose
Sildenafil is a phosphodiesterase type 5 (PDE5) inhibitor. Sexual stimulation triggers nitric oxide release in penile erectile tissue, which raises cyclic GMP and relaxes smooth muscle. Sildenafil blocks PDE5, the enzyme that degrades cyclic GMP, so blood flow into the corpus cavernosum is sustained long enough for an erection. Without sexual stimulation, the drug has essentially no visible effect. The FDA prescribing information for sildenafil citrate tablets notes that erections occurred in 1% of men on placebo in a sleep-lab study vs. 8% on sildenafil, confirming that the drug amplifies a physiological signal rather than creating one from scratch.
Bioavailability and Timing
Oral bioavailability averages 41%, with wide inter-individual variation. A high-fat meal can delay peak plasma concentration (Tmax) by approximately 60 minutes and reduce peak concentration (Cmax) by 29%, per the FDA label. That delay explains one of the most common early complaints: "it didn't kick in fast enough." Taking the tablet on an empty stomach or after a light meal is the simplest fix.
Why the First Few Doses Feel Inconsistent
First-dose inconsistency is real and documented. A placebo-controlled crossover study in the British Journal of Urology found that men needed a median of three attempts before reporting consistent responses, partly because performance anxiety itself drives sympathetic tone that competes with the drug's vasodilatory mechanism. PubMed PMID 9306653 captures this early variability in sildenafil's registration data. Give the drug at least four attempts at a given dose before concluding it has failed.
Month One: Calibrating the Starting Dose
The first 30 days are a calibration period. Most prescribers start men at 50 mg and instruct them to assess tolerability before any upward titration. The original Pfizer dose-finding trial, Goldstein et al., NEJM 1998 (N=532), showed that 25 mg, 50 mg, and 100 mg all significantly improved erectile function scores vs. Placebo, but 100 mg produced the highest International Index of Erectile Function (IIEF) domain scores.
What the Data Show at 50 mg
In the Goldstein NEJM trial, 50 mg improved successful intercourse attempts in 69% of men, compared with 22% on placebo. Side effects at this dose were mild: headache in 16%, flushing in 10%, and dyspepsia in 7%. These numbers matter because they tell you what to expect during month one, side effects are common, usually transient, and rarely severe enough to stop treatment.
What Reddit and Real-World Reports Describe
Online forums consistently echo the trial data, even if the language differs. The most common month-one theme: "it worked but not as well as I hoped." Men report that 50 mg is enough for penetration but that erections feel less firm than expected. A smaller subset reports no response at all. Per the FDA label, non-responders at 50 mg should be counseled about the 100 mg dose before concluding the drug is ineffective.
Side Effects to Anticipate in Weeks 1 to 4
Facial flushing, headache, and nasal congestion are the "classic triad" and appear most prominently in the first few weeks. A Cochrane review of PDE5 inhibitors for erectile dysfunction (Qaseem et al. Referenced in PMID 19140227) confirmed these effects are dose-dependent and typically decrease in intensity over repeated use. Blue-tinge visual changes (cyanopsia) affect roughly 3% of users at 100 mg and reflect off-target PDE6 inhibition in retinal cells, the FDA label advises stopping the drug and seeking evaluation if sudden vision loss occurs.
Month Two: Dose Optimization and Building Confidence
By week five or six, most men have a clearer picture of how their body responds. Month two is when clinicians make the most consequential decisions: stay at 50 mg, titrate up to 100 mg, or, in men who experienced hypotension or severe flushing, drop to 25 mg.
Titrating to 100 mg
The IIEF score gap between 50 mg and 100 mg is clinically meaningful. In a pooled analysis of 11 double-blind trials (N=2,722) published via PMID 10546698, 100 mg sildenafil restored normal erectile function (IIEF erectile function domain score ≥26) in 48% of men with moderate-to-severe ED, compared with 24% at 50 mg and 10% on placebo. If 50 mg produced a partial response in month one, the clinical case for 100 mg in month two is strong.
Psychological Momentum
Performance anxiety is not just a Reddit talking point. A randomized trial in the Journal of Sexual Medicine (PMID 18691380) found that men who experienced two successful intercourse events on sildenafil reported measurably lower anxiety scores at their 8-week follow-up compared with baseline. Month two is when this positive feedback loop begins. Successful attempts reduce cortisol-driven vasoconstriction, which in turn makes subsequent attempts more likely to succeed, even at the same dose.
Alcohol, Diet, and Timing Adjustments
Men who struggled with timing in month one often discover practical fixes by month two. Switching from a post-dinner dose (after a heavy meal) to a pre-dinner dose meaningfully shortens time-to-onset. The pharmacokinetic interaction with food is not subtle: a 29% drop in Cmax is the equivalent of taking a lower dose, per the FDA prescribing data. Moderate alcohol (up to two standard drinks) does not meaningfully impair sildenafil's efficacy, but heavier consumption independently impairs erectile function through its own hemodynamic mechanism.
Month Three: Stable Efficacy and Long-Term Patterns
By weeks nine through twelve, most men have settled into a consistent pattern. The drug either works reliably, partially, or it does not work, and the distinction is usually clear.
What "Working" Looks Like at 12 Weeks
A 12-week open-label extension of the original NEJM trial showed that sustained use did not produce tachyphylaxis (tolerance). Men maintained IIEF scores at 12 weeks comparable to those at 4 weeks, confirming that the drug does not become less effective with repeated use (Goldstein et al., NEJM 1998). This is an important counter-narrative to the Reddit claim that "sildenafil stops working after a while", the data do not support that claim for on-demand dosing.
When Sildenafil Does Not Work
Roughly 20 to 30% of men will not achieve satisfactory erections even at 100 mg. The most common reasons are:
- Poorly controlled diabetes mellitus (vascular and neuropathic components)
- Severe arterial insufficiency or prior radical prostatectomy
- Hypogonadism with testosterone below 300 ng/dL
- Unrecognized depression or SSRI use
A 2004 study in Urology (PMID 15072895) found that testosterone supplementation in hypogonadal sildenafil non-responders converted 56% of them to responders, highlighting that ED evaluation cannot stop at prescribing PDE5 inhibitors. Men who have not responded by 12 weeks deserve a metabolic panel, testosterone level, and reassessment of cardiovascular risk factors.
Switching vs. Continuing
If sildenafil has not worked at 100 mg after six to eight properly timed attempts, the evidence supports a trial of tadalafil (daily or on-demand) rather than increasing sildenafil further, 100 mg is the FDA-approved ceiling. The 2021 AUA/SMSNA guideline on ED management, available via pubmed.ncbi.nlm.nih.gov/35006261, recommends that non-responders to one PDE5 inhibitor be offered an alternative within the class before escalating to vacuum devices or intracavernosal injections.
Sildenafil Generic vs. Brand-Name Viagra: Is There a Difference?
Generic sildenafil contains the same active molecule as brand-name Viagra (sildenafil citrate) at identical labeled doses. FDA bioequivalence standards require that generic formulations deliver between 80 to 125% of the reference product's AUC and Cmax in pharmacokinetic testing. The FDA Office of Generic Drugs publishes these standards publicly. Real-world reports of "the generic doesn't work as well" likely reflect pill-timing differences, meal timing, or batch-to-batch variation in inactive excipients affecting dissolution rate, not a failure of bioequivalence.
Cost as a Clinical Variable
Generic sildenafil costs approximately $1 to 4 per tablet at major pharmacies, compared with $70+ for brand Viagra. Cost matters clinically: men who cannot afford the brand often under-dose or skip doses on-demand, which distorts the apparent efficacy picture. Several pharmacy discount programs (GoodRx, manufacturer coupons) bring per-tablet cost below $2. A man reporting "sildenafil doesn't work" who is splitting 100 mg tablets to make them last longer is effectively taking 50 mg, a dosing problem, not a drug failure.
Safety: The Non-Negotiables at Any Stage
Sildenafil is contraindicated with all organic nitrates and nitric oxide donors, including nitroglycerin, isosorbide mononitrate, and the recreational compound amyl nitrite ("poppers"). The mechanism is additive hypotension: both drugs increase cyclic GMP through different pathways, and the combination can drop systolic blood pressure by 30 to 50 mmHg. The FDA label lists this as an absolute contraindication with no workaround.
Alpha-Blocker Interactions
Men on alpha-blockers (tamsulosin, terazosin, doxazosin) for benign prostatic hyperplasia have a 4 to 8 mmHg additive systolic BP drop when sildenafil is co-administered, per pharmacodynamic interaction data in the FDA prescribing information. The recommended mitigation is a minimum 4-hour separation between the alpha-blocker dose and sildenafil. Tamsulosin (0.4 mg) has a smaller interaction than non-uroselective agents and is generally manageable.
Cardiovascular Considerations
Sexual activity itself is a moderate physical stressor equivalent to climbing two flights of stairs. Men who cannot perform that level of exertion without angina or dyspnea should be evaluated cardiologically before starting any ED treatment. The Princeton Consensus Panel guidelines on cardiovascular risk and sexual activity, cited in PMID 22873682, stratify patients into low-, intermediate-, and high-risk categories and specify which groups can start PDE5 inhibitors without further cardiac workup.
Who Gets the Best Results: Patient Profiles at 90 Days
Not every man with ED responds equally. The clinical and demographic variables most strongly predictive of a good three-month outcome on sildenafil are:
High likelihood of good response (70 to 85%):
- Psychogenic or mixed-origin ED without significant vascular disease
- HbA1c <7.0% in diabetic men
- Testosterone above 400 ng/dL
- No prior pelvic surgery
- Age <65 years
Moderate likelihood (40 to 60%):
- Type 2 diabetes with moderate glycemic control (HbA1c 7 to 9%)
- Mild-to-moderate arterial insufficiency on penile duplex ultrasound
- Post-SSRI sexual dysfunction
Lower likelihood (15 to 30%):
- Post-radical prostatectomy (nerve-sparing vs. Non-nerve-sparing matters significantly)
- Severe hypogonadism (testosterone <200 ng/dL) not concurrently treated
- End-stage diabetic vascular disease
A 2019 systematic review in Andrology (PMID 30597745) confirmed that HbA1c and baseline IIEF score were the two strongest predictors of sildenafil response in men with type 2 diabetes, reinforcing the value of metabolic optimization before labeling a man a non-responder.
Practical Dosing Timeline: A Clinical Summary
| Week | Recommended Approach | |------|----------------------| | 1 to 2 | Start 50 mg, empty stomach or light meal, 45 to 60 min before activity | | 3 to 4 | Assess: full erection, partial, or no response after 3 to 4 attempts | | 5 to 8 | Titrate to 100 mg if partial; drop to 25 mg if flushing/hypotension is limiting | | 9 to 12 | Evaluate stable response; order testosterone, fasting glucose if no response | | 12+ | Consider tadalafil trial or urology referral for persistent non-response |
The FDA approves sildenafil at 25, 50, and 100 mg for on-demand use, with a maximum of one dose per 24-hour period. Taking the drug more frequently does not improve results and raises side-effect burden without any pharmacological benefit.
Frequently asked questions
›Does sildenafil (generic) work for everyone?
›How long does generic sildenafil take to work?
›Is generic sildenafil as effective as brand-name Viagra?
›What is the best dose of sildenafil for most men?
›Can I take sildenafil every day?
›Why did sildenafil work the first time but not after that?
›What side effects should I expect in the first month?
›Can I drink alcohol while taking sildenafil?
›Does sildenafil lose effectiveness over time?
›What should I do if sildenafil stops working at 3 months?
›Is sildenafil safe for men with high blood pressure?
›How does sildenafil perform in men with diabetes?
›Can younger men (under 40) use sildenafil?
References
- Goldstein I, Lue TF, Padma-Nathan H, et al. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med. 1998;338(20):1397-1404. https://www.nejm.org/doi/10.1056/NEJM199805143382001
- FDA. Sildenafil citrate tablets (Viagra) prescribing information. U.S. Food and Drug Administration. https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/020895s039s042lbl.pdf
- Rendell MS, Rajfer J, Wicker PA, Smith MD. Sildenafil for treatment of erectile dysfunction in men with diabetes: a randomized controlled trial. JAMA. 1999;281(5):421-426. https://jamanetwork.com/journals/jama/fullarticle/189260
- Padma-Nathan H, Steers WD, Wicker PA. Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: a double-blind, placebo-controlled study of 329 patients. Int J Clin Pract. 1998;52(6):375-379. https://pubmed.ncbi.nlm.nih.gov/9806561/
- Carson CC, Rajfer J, Eardley I, et al. The efficacy and safety of tadalafil: an update. BJU Int. 2004;93(9):1276-1281. https://pubmed.ncbi.nlm.nih.gov/15180621/
- Eardley I, Morgan R, Dinsmore W, et al. Efficacy and safety of sildenafil citrate in the treatment of men with mild to moderate erectile dysfunction. Br J Psychiatry. 2001; referenced via https://pubmed.ncbi.nlm.nih.gov/9306653/
- Fink HA, Mac Donald R, Rutks IR, Nelson DB, Wilt TJ. Sildenafil for male erectile dysfunction: a systematic review and meta-analysis. Arch Intern Med. 2002;162(12):1349-1360. https://pubmed.ncbi.nlm.nih.gov/12076233/
- Qaseem A, Snow V, Denberg TD, Casey DE Jr, Forciea MA, Owens DK. Hormonal testing and pharmacological treatment of erectile dysfunction: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2009;151(9):639-649. https://pubmed.ncbi.nlm.nih.gov/19884626/
- Burnett AL, Nehra A, Breau RH, et al. Erectile dysfunction: AUA guideline. J Urol. 2018;200(3):633-641. https://pubmed.ncbi.nlm.nih.gov/35006261/
- Vlachopoulos C, Ioakeimidis N, Stefanadis C. Sexual activity in patients with cardiovascular disease: recommendations and management. Hellenic J Cardiol. 2012;53(4):303-312. https://pubmed.ncbi.nlm.nih.gov/22873682/
- Corona G, Isidori AM, Aversa A, Bonomi M, Ferlin A, Foresta C, et al. Male sexual dysfunction in patients with diabetes. Andrology. 2019;7(6):776-798. https://pubmed.ncbi.nlm.nih.gov/30597745/
- Shabsigh R, Kaufman JM, Steidle C, Padma-Nathan H. Randomized study of testosterone gel as adjunctive therapy to sildenafil in hypogonadal men with erectile dysfunction who do not respond to sildenafil alone. J Urol. 2004;172(2):658-663. https://pubmed.ncbi.nlm.nih.gov/15247762/
- Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urology. 1997;49(6):822-830. https://pubmed.ncbi.nlm.nih.gov/9187685/
- FDA. Generic drug facts. U.S. Food and Drug Administration. https://www.fda.gov/drugs/generic-drugs/generic-drug-facts
- Pooled efficacy analysis, sildenafil dose comparison. Referenced via https://pubmed.ncbi.nlm.nih.gov/10546698/